{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:57:29Z","timestamp":1791316649134,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["REDES180170"],"award-info":[{"award-number":["REDES180170"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1U19AI135972"],"award-info":[{"award-number":["1U19AI135972"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["1161971"],"award-info":[{"award-number":["1161971"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["FB210008"],"award-info":[{"award-number":["FB210008"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00edfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["1181799"],"award-info":[{"award-number":["1181799"]}],"id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007457","name":"JPB Foundation","doi-asserted-by":"publisher","award":["2020-215611 (5384"],"award-info":[{"award-number":["2020-215611 (5384"]}],"id":[{"id":"10.13039\/100007457","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1212023"],"award-info":[{"award-number":["1212023"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014631","name":"BHP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009610","name":"Pontificia Universidad Cat\u00f3lica de Chile","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3190706"],"award-info":[{"award-number":["3190706"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3190648"],"award-info":[{"award-number":["3190648"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI132633"],"award-info":[{"award-number":["R01AI132633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ebiom.2022.103972","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T06:30:17Z","timestamp":1648621817000},"page":"103972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in na\u00efve and previously infected individuals"],"prefix":"10.1016","volume":"78","author":[{"given":"Nicol\u00e1s A.","family":"Muena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Garc\u00eda-Salum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Pardo-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen F.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Levican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo I.","family":"Almonacid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefany","family":"Poblete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Strohmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2727-0468","authenticated-orcid":false,"given":"Denise","family":"Haslwanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eugenia","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit K.","family":"Jangra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8259-8960","authenticated-orcid":false,"given":"Arnoldo","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Tischler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5013-6884","authenticated-orcid":false,"given":"Rafael A.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2022.103972_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244126","article-title":"Antibody response to SARS-CoV-2 infection in humans: a systematic review","volume":"15","author":"Post","year":"2020","journal-title":"PLoS ONE"},{"issue":"6521","key":"10.1016\/j.ebiom.2022.103972_bib0002","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.abd7728","article-title":"Robust neutralizing antibodies to SARS-CoV-2 infection persist for months","volume":"370","author":"Wajnberg","year":"2020","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.ebiom.2022.103972_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"issue":"7851","key":"10.1016\/j.ebiom.2022.103972_bib0004","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2022.103972_bib0005","first-page":"1","article-title":"Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset","volume":"2","author":"Anand","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103972_bib0006","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41467-021-23977-1","article-title":"Immunological imprinting of the antibody response in COVID-19 patients","volume":"12","author":"Aydillo","year":"2021","journal-title":"Nat Commun"},{"issue":"10283","key":"10.1016\/j.ebiom.2022.103972_bib0007","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(21)00782-0","article-title":"Correlates of protection from SARS-CoV-2 infection","volume":"397","author":"Krammer","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103972_bib0008","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103972_bib0009","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","article-title":"Immunological considerations for COVID-19 vaccine strategies","volume":"20","author":"Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2022.103972_bib0010","first-page":"430","article-title":"Booster doses for inactivated COVID-19 vaccines: if, when, and for whom","author":"Croda","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103972_bib0011","series-title":"SAGE Working Group on COVID-19 Vaccines - Evidence Assessment: Sinovac\/CoronaVac COVID-19 Vaccine","year":"2021"},{"key":"10.1016\/j.ebiom.2022.103972_bib0012","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"32","key":"10.1016\/j.ebiom.2022.103972_bib0013","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2022.103972_bib0014","series-title":"COVID-19 Vaccines WHO Meeting on Correlates of Protection - R&DBlueprint","year":"2021"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103972_bib0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"64","key":"10.1016\/j.ebiom.2022.103972_bib0016","doi-asserted-by":"crossref","first-page":"eabj2901","DOI":"10.1126\/sciimmunol.abj2901","article-title":"Early cross-coronavirus reactive signatures of humoral immunity against COVID-19","volume":"6","author":"Kaplonek","year":"2021","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103972_bib0017","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103972_bib0018","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2022.103972_bib0019","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103972_bib0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103972_bib0021","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1002\/cpmc.108","article-title":"An in vitro microneutralization assay for SARS-CoV-2 serology and drug screening","volume":"58","author":"Amanat","year":"2020","journal-title":"Curr Protoc Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103972_bib0022","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103972_bib0023","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","article-title":"A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity","volume":"18","author":"Legros","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.103972_bib0024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"10.1016\/j.ebiom.2022.103972_bib0025","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ebiom.2022.103972_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"25","key":"10.1016\/j.ebiom.2022.103972_bib0027","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of two RNA-based COVID-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.103972_bib0028","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","author":"Turner","year":"2021","journal-title":"Nature"},{"issue":"56","key":"10.1016\/j.ebiom.2022.103972_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abg6916","article-title":"Prolonged evolution of the human B cell response to SARS-CoV-2 infection","volume":"6","author":"Sakharkar","year":"2021","journal-title":"Sci Immunol"},{"issue":"58","key":"10.1016\/j.ebiom.2022.103972_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.abi6950","article-title":"Distinct antibody and memory B cell responses in SARS-CoV-2 naive and recovered individuals following mRNA vaccination","volume":"6","author":"Goel","year":"2021","journal-title":"Sci Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.103972_bib0031","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1016\/j.immuni.2021.09.011","article-title":"mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants","volume":"54","author":"Sokal","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2022.103972_bib0032","first-page":"1442","article-title":"Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers","author":"Benjamanukul","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2022.103972_bib0033","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijid.2021.09.060","article-title":"Comparison of an inactivated COVID19 vaccine-induced antibody response with concurrent natural Covid19 infection","volume":"113","author":"Azak","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.103972_bib0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jmv.27350","article-title":"SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen","volume":"94","author":"Keskin","year":"2022","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2022.103972_bib0035","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1016\/S2666-7568(21)00253-1","article-title":"Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England","volume":"2","author":"Jeffery-Smith","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103972_bib0036","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jamainternmed.2021.2959","article-title":"Assessment of SARS-CoV-2 reinfection 1 year after primary infection in a population in Lombardy, Italy","volume":"181","author":"Vitale","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ebiom.2022.103972_bib0037","first-page":"294","article-title":"Re-infection with SARS-CoV-2 in patients undergoing serial laboratory testing","author":"Qureshi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6526","key":"10.1016\/j.ebiom.2022.103972_bib0038","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1126\/science.abe9728","article-title":"Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic","volume":"371","author":"Buss","year":"2021","journal-title":"Science"},{"issue":"10273","key":"10.1016\/j.ebiom.2022.103972_bib0039","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(21)00183-5","article-title":"Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence","volume":"397","author":"Sabino","year":"2021","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.ebiom.2022.103972_bib0040","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1056\/NEJMc2110300","article-title":"National study group for C-E. Efficacy of natural immunity against SARS-CoV-2 reinfection with the beta variant","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2022.103972_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v13112329","article-title":"Dynamics of neutralizing antibody responses following natural SARS-CoV-2 infection and correlation with commercial serologic tests. A reappraisal and indirect comparison with vaccinated subjects","volume":"13","author":"Gillot","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.ebiom.2022.103972_bib0042","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an Inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.ebiom.2022.103972_bib0043","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"10296","key":"10.1016\/j.ebiom.2022.103972_bib0044","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2022.103972_bib0045","first-page":"1","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in a subgroup of healthy adults in Chile","author":"Bueno","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2022.103972_bib0046","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/infdis\/jiab396","article-title":"Clinical, immunological, and virological SARS-CoV-2 phenotypes in obese and nonobese military health system beneficiaries","volume":"224","author":"Epsi","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2022.103972_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ebiom.2022.103972_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245424","article-title":"Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients","volume":"16","author":"Frasca","year":"2021","journal-title":"PLoS ONE"},{"issue":"10309","key":"10.1016\/j.ebiom.2022.103972_bib0049","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:34:29Z","timestamp":1778873669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":49,"alternative-id":["S2352396422001566"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103972","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.17.21257197","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in na\u00efve and previously infected individuals","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.103972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103972"}}